Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of anti-glaucoma agents on intraocular pressure spikes after intravitreal bevacizumab injection
IRCT20230330057787N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Sep 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of bevacizumab in post-injection intraocular pressure spike, sponsored by Zahedan University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
bevacizumab
03
Conditions
post-injection intraocular pressure spike
Beyond the preview
Go deeper on IRCT20230330057787N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230330057787N1.